Wells Fargo (WFC)

90.29
+0.84 (0.94%)
NYSE· Last Trade: Sep 11th, 4:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close89.45
Open90.74
Bid90.00
Ask90.51
Day's Range89.76 - 91.16
52 Week Range72.78 - 97.76
Volume12,879,435
Market Cap370.77B
PE Ratio (TTM)14.40
EPS (TTM)6.3
Dividend & Yield1.800 (1.99%)
1 Month Average Volume12,396,169

Chart

About Wells Fargo (WFC)

Wells Fargo is a leading financial services company that provides a wide range of banking, investment, and mortgage products and services to individuals, businesses, and institutions. With a national presence, Wells Fargo operates through a network of branches and ATMs, offering services such as personal and commercial banking, wealth management, and asset management. The company is committed to supporting its customers' financial needs while also focusing on community engagement and sustainable practices. In addition to traditional banking services, Wells Fargo is involved in various financial markets and investment banking activities, helping clients navigate complex financial landscapes. Read More

News & Press Releases

Intuitive Surgical Sees Procedure Growth Despite U.S. Slowdown and China Pressuremarketbeat.com
Intuitive Surgical (NASDAQ:ISRG) executives said the company remains focused on global procedure growth, while acknowledging a recent deceleration in U.S. procedures and policy-related uncertainty affecting hospitals. Speaking at a Wells Fargo conference, Executive Vice President, CFO and Enterpris
Via MarketBeat · September 11, 2026
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potentialmarketbeat.com
Amgen (NASDAQ:AMGN) executives highlighted growth across its key commercial products, progress in late-stage development programs and a continued focus on profitability and cash returns during a Wells Fargo biotech and pharma discussion. Chief Financial Officer Thomas Dittrich, who recently returne
Via MarketBeat · September 11, 2026
RH Analysts Cut Price Targets After Q2 Results, But Estates Collection Could Fuel Growthbenzinga.com
RH analysts revised price targets after mixed second-quarter results, with TD Cowen, Wells Fargo, UBS and BofA Securities lowering their targets.
Via Benzinga · September 11, 2026
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Monthsmarketbeat.com
OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of early-stage clinical programs, external collaborations and capital available to fund development. Speaking
Via MarketBeat · September 11, 2026
Caterpillar Sees Strong 2026 Start as Data Center Power Demand Fuels Expansionmarketbeat.com
Caterpillar (NYSE:CAT) Chairman and CEO Joe Creed said the company has started 2026 with strong demand across its three operating segments, supported by power-generation activity, construction equipment sales and improving orders in resource industries. Speaking at a Wells Fargo Securities event, C
Via MarketBeat · September 10, 2026
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’benzinga.com
CNBC’s final trades: INFL, Wells Fargo, Nutrien and Thermo Fisher. Wells Fargo beat Q2 estimates; Nutrien missed earnings but topped sales.
Via Benzinga · September 10, 2026
Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Modemarketbeat.com
Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined the company’s priorities across HIV, oncology and inflammation at the Wells Fargo conference, describing a portfolio that has expanded through internal development and acquisitions and is now entering a period of prioritizat
Via MarketBeat · September 10, 2026
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fallinvestors.com
Here's why Oscar Health may be hardest hit from CVS' comments.
Via Investor's Business Daily · September 9, 2026
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stagemarketbeat.com
Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for the 2022 through 2027 period, citing a portfolio shift toward cardiovascular products, operating-m
Via MarketBeat · September 9, 2026
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conferencemarketbeat.com
AbbVie (NYSE:ABBV) executives outlined growth plans across immunology, oncology and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a pipeline of combination therapies and an approach to business development focused on assets that fit i
Via MarketBeat · September 9, 2026
Editas Medicine Eyes First Human Trial for CRISPR Cholesterol Therapy EDIT-401marketbeat.com
Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial hypercholesterolemia, Chief Executive Officer Gilmore O’Neill said during a Wells Fargo discussion. O’Ne
Via MarketBeat · September 9, 2026
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conferencemarketbeat.com
Medtronic (NYSE:MDT) executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies. Speaking at the Wells Fargo Healthcare Conference, Chairman and Chief
Via MarketBeat · September 8, 2026
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Acceleratesmarketbeat.com
McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id
Via MarketBeat · September 8, 2026
Wells Fargo to Present at the Barclays Global Financial Services Conference
Wells Fargo & Company (NYSE: WFC) said today that Chief Financial Officer Mike Santomassimo will present at the Barclays Global Financial Services Conference on Tuesday, September 15, 2026 at 8:15 a.m. ET.
By Wells Fargo & Company · Via Business Wire · September 8, 2026
Why Nutanix Stock Ascended in Augustfool.com
It ended its latest fiscal year quite impressively.
Via The Motley Fool · September 8, 2026
Enhancing Comfort and Reliability: Plumbtech, LLC Expands Support for Local Property Owners With HVAC and Plumbing Services in Watertown, CT
Watertown, CT - Plumbtech, LLC is expanding its HVAC and plumbing support in Watertown and surrounding communities. Founded in 2018, the company provides installation, maintenance, replacement, and system upgrade services. The expanded focus gives local property owners access to a contractor experienced in both conventional systems and more specialized mechanical projects.
Via GetFeatured · September 7, 2026
Why Innodata Stock Tumbled by 10% Last Monthfool.com
It wasn't because of the quarterly earnings report it published that month.
Via The Motley Fool · September 5, 2026
From Launch Party to Federal Probe: What Went Wrong With Tesla's Cybercab in 24 Hoursfool.com
The much-anticipated launch led to a share price plunge.
Via The Motley Fool · September 4, 2026
These Analysts Revise Their Forecasts On Phreesia After Q2 Resultsbenzinga.com
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.
Via Benzinga · September 3, 2026
Right The 1st Time Marks 18 Years of Growth as Woman-Owned Company
Indianapolis, Indiana - September 02, 2026 - Right The 1st Time, the woman-owned residential cleaning company founded by Amy White in 2008, is marking its 18th year of operation and...
Via Press Advantage · September 2, 2026
Strikepoint Gold’s Blockbuster Deal with Newmont, CEO Interviewtalkmarkets.com
In the past few months, investment banks have updated year end views on gold (“Au”) to US$4,500-$5,100/oz vs. the current price of ~$4,380. For example, Go
Via Talk Markets · September 1, 2026
Jax Humor: Best-Selling Jacksonville Stickers $9.04 on 904 Day
Jacksonville, FL - August 31, 2026 - Jax Humor, the best selling Jacksonville merchandise and media company, announced today that its Jacksonville Sticker Pack will be priced at $9.04 for 904 Day: Friday, September 4, 2026. The pack normally sells for $15.00. The promotion recognizes 904 Day, the annual celebration Jacksonville residents observe on the date that matches the region's area code.
Via AB Newswire · August 31, 2026
Socure Reaches $5.2 Billion Valuation and Acquires Fravity to Automate Fraud Operationstalkmarkets.com
Digital identity verification and fraud prevention provider Socure has achieved a $5.2 billion valuation and buys following a strategic growth investment l
Via Talk Markets · August 31, 2026
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via StockStory · August 31, 2026
2 Premier Artificial Intelligence (AI) Stocks That Can Plunge Up to 63%, According to Select Wall Street Analystsfool.com
Wall Street's hottest trend could prove costly for investors in two of the highest-flying AI stocks.
Via The Motley Fool · August 28, 2026